Interleukin-2 modulates the responsiveness to angiotensin II in cultured vascular smooth muscle cells. 1997

T Nabata, and K Fukuo, and S Morimoto, and S Kitano, and N Momose, and A Hirotani, and T Nakahashi, and A Nishibe, and S Hata, and T Niinobu, and T Suhara, and M Shimizu, and H Ohkuma, and S Sakurai, and H Nishimaki, and T Ogihara
Department of Geriatric Medicine, Osaka University Medical School, Japan.

Preincubation with interleukin-2 (IL-2), a T cell-derived cytokine, enhanced the increase in intracellular Ca2+ ([Ca2+]i) induced by angiotensin II (AII) in vascular smooth muscle cells (VSMC). IL-2 itself did not affect the basal [Ca2+]i level or the maximal response of [Ca2+]i increase induced by AII. Furthermore, IL-2-induced enhancement was not observed in the absence of extracellular Ca2+, suggesting that IL-2 enhances Ca2+ influx induced by AII. IL-2 also enhanced the stimulation of DNA synthesis induced by AII, although IL-2 alone did not stimulate DNA synthesis. Genistein, an inhibitor of protein tyrosine kinases, significantly inhibited IL-2-induced enhancement of both Ca2+ influx and DNA synthesis induced by AII. A neutralizing antibody against heparin-binding epidermal growth factor-like growth factor (HB-EGF) partially inhibited IL-2-induced enhancement of DNA synthesis induced by AII. These findings suggest that autocrine HB-EGF is partially involved in the mechanism of IL-2-induced enhancement of DNA synthesis. On the other hand IL-2 stimulated both glycosaminoglycan (GAG) and prostacyclin syntheses and enhanced the stimulation of both GAG and prostacyclin syntheses induced by AII. Therefore, IL-2 may play important roles in the pathogenesis of atherosclerosis and vascular disease by modulating the responsiveness to AII in VSMC.

UI MeSH Term Description Entries
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D011464 Epoprostenol A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY). Prostacyclin,Prostaglandin I2,Epoprostanol,Epoprostenol Sodium,Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer,Flolan,Prostaglandin I(2),Veletri
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004261 DNA Replication The process by which a DNA molecule is duplicated. Autonomous Replication,Replication, Autonomous,Autonomous Replications,DNA Replications,Replication, DNA,Replications, Autonomous,Replications, DNA
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005260 Female Females
D006025 Glycosaminoglycans Heteropolysaccharides which contain an N-acetylated hexosamine in a characteristic repeating disaccharide unit. The repeating structure of each disaccharide involves alternate 1,4- and 1,3-linkages consisting of either N-acetylglucosamine (see ACETYLGLUCOSAMINE) or N-acetylgalactosamine (see ACETYLGALACTOSAMINE). Glycosaminoglycan,Mucopolysaccharides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T Nabata, and K Fukuo, and S Morimoto, and S Kitano, and N Momose, and A Hirotani, and T Nakahashi, and A Nishibe, and S Hata, and T Niinobu, and T Suhara, and M Shimizu, and H Ohkuma, and S Sakurai, and H Nishimaki, and T Ogihara
October 2009, Biochemical and biophysical research communications,
T Nabata, and K Fukuo, and S Morimoto, and S Kitano, and N Momose, and A Hirotani, and T Nakahashi, and A Nishibe, and S Hata, and T Niinobu, and T Suhara, and M Shimizu, and H Ohkuma, and S Sakurai, and H Nishimaki, and T Ogihara
March 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
T Nabata, and K Fukuo, and S Morimoto, and S Kitano, and N Momose, and A Hirotani, and T Nakahashi, and A Nishibe, and S Hata, and T Niinobu, and T Suhara, and M Shimizu, and H Ohkuma, and S Sakurai, and H Nishimaki, and T Ogihara
March 2009, Clinical science (London, England : 1979),
T Nabata, and K Fukuo, and S Morimoto, and S Kitano, and N Momose, and A Hirotani, and T Nakahashi, and A Nishibe, and S Hata, and T Niinobu, and T Suhara, and M Shimizu, and H Ohkuma, and S Sakurai, and H Nishimaki, and T Ogihara
June 2005, Clinical science (London, England : 1979),
T Nabata, and K Fukuo, and S Morimoto, and S Kitano, and N Momose, and A Hirotani, and T Nakahashi, and A Nishibe, and S Hata, and T Niinobu, and T Suhara, and M Shimizu, and H Ohkuma, and S Sakurai, and H Nishimaki, and T Ogihara
February 1982, The Journal of cell biology,
T Nabata, and K Fukuo, and S Morimoto, and S Kitano, and N Momose, and A Hirotani, and T Nakahashi, and A Nishibe, and S Hata, and T Niinobu, and T Suhara, and M Shimizu, and H Ohkuma, and S Sakurai, and H Nishimaki, and T Ogihara
April 1989, Hypertension (Dallas, Tex. : 1979),
T Nabata, and K Fukuo, and S Morimoto, and S Kitano, and N Momose, and A Hirotani, and T Nakahashi, and A Nishibe, and S Hata, and T Niinobu, and T Suhara, and M Shimizu, and H Ohkuma, and S Sakurai, and H Nishimaki, and T Ogihara
January 1991, Journal of hypertension,
T Nabata, and K Fukuo, and S Morimoto, and S Kitano, and N Momose, and A Hirotani, and T Nakahashi, and A Nishibe, and S Hata, and T Niinobu, and T Suhara, and M Shimizu, and H Ohkuma, and S Sakurai, and H Nishimaki, and T Ogihara
November 2000, Hypertension (Dallas, Tex. : 1979),
T Nabata, and K Fukuo, and S Morimoto, and S Kitano, and N Momose, and A Hirotani, and T Nakahashi, and A Nishibe, and S Hata, and T Niinobu, and T Suhara, and M Shimizu, and H Ohkuma, and S Sakurai, and H Nishimaki, and T Ogihara
January 2000, Hypertension (Dallas, Tex. : 1979),
T Nabata, and K Fukuo, and S Morimoto, and S Kitano, and N Momose, and A Hirotani, and T Nakahashi, and A Nishibe, and S Hata, and T Niinobu, and T Suhara, and M Shimizu, and H Ohkuma, and S Sakurai, and H Nishimaki, and T Ogihara
October 1992, The Journal of biological chemistry,
Copied contents to your clipboard!